DJ Biogen Inc. Stock Underperforms Friday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Biogen Inc. $(BIIB)$ shed 1.35% to $218.50 Friday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index falling 0.25% to 7,711.76 and Dow Jones Industrial Average falling 0.02% to 53,559.99.
The stock's fall snapped a five-day winning streak.
Biogen Inc. closed 1.95% short of its 52-week high of $222.85, which the company achieved on August 25th.
The stock underperformed when compared to some of its competitors Friday, as Johnson & Johnson $(JNJ)$ rose 0.85% to $268.04, Pfizer Inc. $(PFE)$ fell 0.21% to $27.96, and AbbVie Inc. $(ABBV)$ fell 1.03% to $255.48.
Trading volume (516,806) remained 667,372 below its 50-day average volume of 1.2 M.
Data source: Dow Jones Market Data, FactSet. Data compiled August 28, 2026.